Researchers at UC San Francisco have made a significant discovery regarding a protein that may be a major contributor to brain aging.
FTL1 Identified as a Key Factor
In their quest to uncover age-related changes, the team investigated gene and protein variations in the hippocampus of mice over time. Among the many factors analyzed, one protein, known as FTL1, consistently exhibited notable differences between younger and older specimens.
Older mice displayed elevated levels of FTL1, which correlated with reduced neuronal connections in the hippocampus and poorer performance on cognitive assessments.
Impact of FTL1 on Brain Functionality
When the researchers artificially increased FTL1 levels in younger mice, remarkable changes were observed. Their brain structures began resembling those of older mice, affecting their behavior and cognitive abilities.
Further laboratory studies provided deeper insights. Neurons engineered to produce excessive FTL1 developed simpler structures, forming short, singular extensions rather than the intricate, branching networks characteristic of healthy cells.
Reversing Cognitive Decline by Reducing FTL1
The most unexpected outcome occurred when the scientists decreased FTL1 levels in older mice. This intervention led to a noticeable recovery, with increased neuronal connections and improved performance on memory tests.
"This represents a genuine reversal of impairments," stated Saul Villeda, PhD, associate director at the UCSF Bakar Aging Research Institute and senior author of the study published in Nature Aging. "It goes beyond merely delaying or preventing symptoms."
Metabolic Connections Indicate New Treatment Avenues
Additional experiments revealed that FTL1 also influences the energy utilization of brain cells. In older mice, elevated FTL1 levels were linked to a slowdown in cellular metabolism within the hippocampus. However, administering a compound that enhances metabolism mitigated these adverse effects.
Bright Prospects for Future Therapies
Villeda envisions that these findings could lead to innovative treatments targeting FTL1 to counteract its detrimental effects in the brain.
"We are uncovering more possibilities to alleviate the severe consequences of aging," he remarked. "This is an encouraging time for advancing our understanding of aging biology."